Discontinuation report THALLOUS CHLORIDE TI 201 INJECTION
Report ID | 129592 |
Drug Identification Number | Not Applicable/non applicable |
Brand name | THALLOUS CHLORIDE TI 201 INJECTION |
Common or Proper name | Thallous Chloride TI 201 Injection |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | THALLIUM CHLORIDE |
Strength(s) | 37MBq |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 mL |
ATC code | V09GX |
ATC description | |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-06-04 |
Actual discontinuation date | 2021-06-04 |
Remaining supply date | 2021-06-04 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@ge.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-12-04 | English | Compare |
v2 | 2020-12-04 | English | Compare |
v3 | 2020-12-04 | French | Compare |
v4 | 2020-12-04 | English | Compare |
v5 | 2020-12-04 | French | Compare |
v6 | 2021-06-04 | English | Compare |
v7 | 2021-06-04 | French | Compare |
v8 | 2021-06-05 | English | Compare |
Showing 1 to 8 of 8